Aprea Therapeutics
APRE
#10269
Rank
A$12.37 M
Marketcap
A$1.08
Share price
-2.80%
Change (1 day)
-72.24%
Change (1 year)

Market capitalization of Aprea Therapeutics (APRE)

Market cap: A$12.37 Million

As of March 2026 Aprea Therapeutics has a market cap of A$12.37 Million. This makes Aprea Therapeutics the world's 10269th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aprea Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$12.37 M20.86%
2025A$10.23 M-65.24%
2024A$29.44 M14.23%
2023A$25.77 M-0%
2022A$25.77 M-69.66%
2021A$84.97 M-37.32%
2020A$0.13 B-90.15%
2019A$1.37 B

End of Day market cap according to different sources

On Mar 11th, 2026 the market cap of Aprea Therapeutics was reported to be:

A$12.72 Million
by Nasdaq info icon info icon
A$12.72 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Magellan Health
MGLN
A$3.53 B 28,453.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
A$4.69 B 37,814.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
A$1.93 B 15,519.06%๐Ÿ‡บ๐Ÿ‡ธ USA